Ortoton Parenteral (Methocarbamol)

Methocarbamol, the active ingredient in Ortoton Parenteral, is a muscle relaxant presented as a parenteral solution for intramuscular, intravenous use. It treats muscle spasm and skeletal muscle pain in adults.

GNH USA supplies Ortoton Parenteral as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals worldwide.

Methocarbamol acts on skeletal muscle spasm and related pain conditions. - Muscle spasm: provides relief of involuntary skeletal muscle contractions. - Skeletal muscle pain: reduces pain associated with strained or injured muscles. - Acute musculoskeletal injuries: facilitates muscle relaxation to aid physiotherapy and recovery. - Post‑operative muscle spasm: helps control spasm after surgical procedures.

Methocarbamol may cause a range of adverse reactions.

Common Side Effects: - Drowsiness: feeling unusually sleepy or fatigued. - Dizziness: sensation of light‑headedness or unsteadiness. - Nausea: mild to moderate upset stomach. - Headache: mild to moderate pain in the head. - Flushing: transient redness of the skin. - Weakness: reduced muscular strength.

Serious or Rare Side Effects: - Severe hypotension: marked drop in blood pressure. - Anaphylactic reaction: sudden severe allergic response. - Hepatotoxicity: signs of liver injury such as jaundice. - Cardiac arrhythmia: irregular heart rhythm. - Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Respiratory depression: difficulty breathing.

Before using Methocarbamol, consider the following safety measures. - Pregnancy: consult a prescriber; limited safety data are available. - Breastfeeding: use with caution; methocarbamol may pass into milk. - Renal impairment: dose adjustment may be required. - Hepatic impairment: monitor liver function and adjust dose if needed. - Elderly patients: increased sensitivity to CNS effects; monitor closely. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Methocarbamol can interact with other medications, requiring careful management.

Major Interactions (Avoid): - CNS depressants (e.g., barbiturates, opioids): additive sedation and respiratory depression. - Alcohol: increased risk of profound drowsiness and hypotension.

Moderate Interactions (Monitor Closely): - Antihypertensives: may enhance blood‑pressure‑lowering effects. - Anticholinergic agents: may reduce the therapeutic efficacy of methocarbamol. - Other muscle relaxants: increased likelihood of side‑effects such as weakness and dizziness. - Sedating antihistamines: may amplify drowsiness.